https://clinicaltrials.gov/ct2/show/NCT03848806?type=Intr&cond=Psoriasis&lupd_s=02%2F20%2F2019&lupd_d=14
Condition : Psoriasis
Interventions : Drug: HAT1; Drug: Calcipotriol
Sponsor : Haus Bioceuticals
Completed
Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis
NCT03848806
Thu, 21 Feb 2019 12:00:00 EST
Last Update Posted: 02/21/2019
Update: Completed
